| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| CREB1 |
BMDM (bone marrow-derived macrophages) |
|
Permissive
Robust
|
Mus musculus |
GSE64844
...
|
MA0018.4
|
| CREB3L1 |
K562 (myelogenous leukemia) |
|
Permissive
|
Homo sapiens |
ENCSR109YGM
|
MA0839.1
|
| CTCF |
Ishikawa (endometrial adenocarcinoma) |
1 h with 0.02% Dimethyl sufloxide (DMSO) (Myers) |
Permissive
Robust
|
Homo sapiens |
ENCSR000BQE
|
MA0139.1
|
| CTCF |
whole organism (development stage: embryonic) |
strain: CTCF-GFP, genotype: y[1] w[*]; P{y[+7.7] w[+mC]=CTCF-GFP.FPTB}attP40, sex:mixed |
Permissive
Robust
|
Drosophila melanogaster |
ENCSR661BEZ
|
MA0531.1
|
| CTCF |
pro-B cells |
RAG1 KO |
Permissive
Robust
|
Mus musculus |
GSE21978
...
|
MA0139.1
|
| CTCF |
CD36+ erythroid cells |
BRG1 KD shLuc control |
Permissive
Robust
|
Homo sapiens |
GSE26501
...
|
MA0139.1
|
| CTCF |
CD36+ erythroid cells |
BRG1 RNAi KD |
Permissive
Robust
|
Homo sapiens |
GSE26501
...
|
MA0139.1
|
| CTCF |
G1E-ER4 (embryonic stem cells) |
24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison) |
Permissive
Robust
|
Mus musculus |
ENCSR000DIR
...
|
MA0139.1
|
| CTCF |
MEL cell line |
5 d with 2% Dimethyl sufloxide (DMSO) (Weissman) |
Permissive
Robust
|
Mus musculus |
ENCSR000ETE
...
|
MA0139.1
|
| CTCF |
K562 (myelogenous leukemia) |
5-aza-2’-deoxycytidine (decitabine; Sigma, A3656) dissolved in DMSO to 10mM. Drug was administered at 1uM daily for 3 days. Control K562 cells were mock treated with DMSO. |
Permissive
Robust
|
Homo sapiens |
GSE50610
...
|
MA0139.1
|
Showing 10 records in page 33
from 358 pages